<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-78120</identifier>
<setSpec>0212-6567</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Diabetic nephropathy and cardiovascular risk</dc:title>
<dc:description xml:lang="en">The importance of the early detection of diabetic nephropathy is because it is a cardiovascular risk marker and it indicates the existence of vascular changes associated to an increase risk of having a cardiovascular event in diabetes mellitus type 1 (DM 1), as well as in type 2 (DM 2).Microalbuminuria is a risk factor for overall cardiovascular and coronary mortality in the patients with DM 1.Total mortality is increased in patients with DM 2 and microalbuminuria with a RR of 1.8, and it is related to microalbuminuria levels even below the considered normal range (20mg/min and/or 30mg/day). For this reason, the definition of microalbuminuria must be reviewed in the patients with DM 2.More studies are needed to confirm the predictive power of microalbuminuria in cardiovascular and coronary disease(AU)</dc:description>
<dc:creator>Ávila Lachica, Luis</dc:creator>
<dc:creator>Gómez García, M Carmen</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La importancia de la detección precoz de la nefropatía diabética radica en que es un marcador de riesgo cardiovascular y nos indica la existencia de una alteración vascular que se asocia a un aumento del riesgo de padecer un evento cardiovascular, tanto en la diabetes Mellitus tipo 1 (DM 1) como en la tipo 2 (DM 2).La microalbuminuria es un factor de riesgo para la mortalidad total, cardiovascular y coronaria, en los pacientes con DM 1.La mortalidad total se encuentra aumentada en pacientes con DM 2 y microalbúmina, con un RR del 1.8 y se relaciona con niveles de microalbúmina incluso por debajo del rango considerado como normal (20mg/minuto y/o 30mg/día). Por ello, la definición de microalbúmina debe ser revisada en los pacientes con DM 2.Se necesitan más trabajos que confirmen el poder predictivo de la microalbuminuria sobre la enfermedad cardiovascular y coronaria(AU)</dc:description>
<dc:source>Aten Primaria;42(3): 173-175, mar. 2010.</dc:source>
<dc:identifier>ibc-78120</dc:identifier>
<dc:title xml:lang="es">Nefropatía diabética y riesgo cardiovascular</dc:title>
<dc:subject>^d422^s22016</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d16902</dc:subject>
<dc:subject>^d2359^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d2359^s22054</dc:subject>
<dc:subject>^d3951^s22016</dc:subject>
<dc:subject>^d3944^s22016</dc:subject>
<dc:subject>^d3951^s22012</dc:subject>
<dc:subject>^d3944^s22012</dc:subject>
<dc:subject>^d3944^s22067</dc:subject>
<dc:subject>^d422^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201003</dc:date>
</metadata>
</record>
</ibecs-document>
